Our leadership in essential plasma-derived medicines enables patients with rare and chronic diseases – sometimes life-threatening – to lead healthier lives. They often have no alternative treatments. We produce our lifesaving medicines, made from plasma proteins, thanks to the generosity of donors who entrust their donations to our growing global network of donor centers, the world’s largest.
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information, and services that enable hospitals to efficiently deliver medical care.
